Dr. Patricia Conrod
Dr. Patricia Conrod, Ph.D. is the Study Lead for the CUSP Trial. Dr Conrod is a Registered Clinical Psychologist with the Ordres des Psychologues du Québec, Professor in Psychiatry, Université de Montréal and Senior Clinical Lecturer in the Addictions Department, King’s College London. She is based at the CHU Sainte-Justine Mother and Child Hospital Centre in Montreal. Her research focuses on cognitive, personality and biological risk factors for the development and maintenance of drug abuse and the factors that mediate the co-occurrence of addictive behaviours with other mental disorders. Her experimental research focuses on factors that make people more susceptible to seek out behavioral reinforcement from drugs of abuse.
Dr. Hayley Hamilton
Dr. Hayley Hamilton, Ph.D. is the Study Lead for the Ontario study site. is a Senior Scientist with the Institute for Mental Health Policy Research at CAMH. She is also an Associate Professor in the Dalla Lana School of Public Health at the University of Toronto, and Co-Director of the Collaborative Program in Addiction Studies at the University of Toronto.Dr. Hamilton’s research work includes the public health monitoring of mental health and addictive behaviours, and the influence of individual, social and other factors on aspects of health and behaviour. She has also conducted studies on the mental health needs of diverse populations (including immigrants, youth in the justice system), stigma toward mental illness and addiction, and the influence of early experiences on health outcomes over the long term. She also co-leads the CAMH population surveys of youth (Ontario Student Drug Use and Health Survey) and adults (CAMH Monitor).
Dr. Marvin Krank
Dr. Marvin Krank, Ph.D. is the Study Lead for the British Columbia study site. Dr. Krank is a Professor of psychology at UBC’s Okanagan campus. He served as Dean of Graduate Studies until July, 2011. For the previous twelve years, Dr. Krank was Vice-President (Academic), Associate Vice-President (Academic) and Dean of Arts and Education at Okanagan University College. Dr. Krank moved to Kelowna from his position as Head of Psychology at Mount Alison University where he taught for ten years. He also taught at Memorial University of Newfoundland and the University of Toronto. He has been an Adjunct Professor at the Oregon Health Sciences University, the University of British Columbia and the University of Washington.
Dr. Sherry Stewart
Dr. Sherry Stewart, Ph.D. is the Study Lead for the Nova Scotia study site. Dr Stewart is a Professor in the Departments of Psychiatry, Psychology, and Community Health and Epidemiology at Dalhousie University, as well as a licenced clinical psychologist in the province of Nova Scotia. She is well known for her research on psychological factors contributing to alcohol abuse, pathological gambling, and the comorbidity of mental health and addictive disorders. Dr. Stewart holds a Governor-in-Council appointment with the Canadian Centre of Substance Abuse, and is Editor-in-Chief for the Journal of Gambling Issues. Dr. Stewart receives funding from several research agencies including the Social Sciences and Humanities Research Council, the Nova Scotia Health Research Foundation, the Nova Scotia Gaming Foundation, and the Ontario Problem Gambling Research Centre.
Dr. Jürgen Rehm
Dr. Jürgen Rehm, Ph.D. is the Study Lead for the Evaluation of the CUSP Trial. Dr. Jürgen Rehm is Senior Scientist in the Institute for Mental Health Policy Research and in the Campbell Family Mental Health Research Institute at CAMH. He is Professor and Inaugural Chair of Addiction Policy in the Dalla Lana School of Public Health at the University of Toronto. Dr. Rehm is a leader in generating and analyzing the scientific data needed to inform clinicians and policy-makers of strategies to reduce alcohol-, tobacco-, and other drug-related harm. His recent research has more and more included interactions between socio-economic status, poverty and substance use, including analysis of policies and interventions with respect to reducing or increasing inequalities. His work has been awarded with numerous awards and prizes, most importantly, the Jellinek Memorial Award (2003) and the European Addiction Research Award (2017).
Dr. Chris Richardson
Dr. Chris Richardson, Ph.D. is currently an Associate Professor in the School of Population and Public Health where his research activities are focused on examining aspects of biopsychosocial development in adolescence (e.g., impulsivity, sensation seeking, resilience) and their relationships with patterns of tobacco, alcohol, marijuana and other drug use. He is also a Scientist with the Centre for Health Evaluation and Outcomes Sciences at St. Paul’s Hospital where he leads the Psychosocial Epidemiology Program and works with the Inner City Youth Program on a variety of projects examining the role of mental illness, substance use and homelessness on the psycho-social functioning of street involved youth.
Dr. David Smith
Dr. David Smith is a child and adolescent psychiatrist in Vernon and the Medical Director in Child and Adolescent Psychiatry of the Psychiatric services for Interior Health in the Okanagan, British Columbia.
Dr. Joanna Henderson
Dr. Joanna Henderson, Ph.D. is Director of the Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health and Interim Implementation Director of the Cundill Centre for Child and Youth Depression at CAMH. She is also Senior Scientist in the Child, Youth and Emerging Adult Program at CAMH, and Associate Professor in the Department of Psychiatry at the University of Toronto.
Dr Ranmalie Jayasinha
Dr Ranmalie Jayasinha Ph.D. is the coordinator for the CUSP Trial and a postdoctoral fellow at the Université de Montréal. Their key interests are focused on the health, wellbeing and rights of adolescents and young adults from Indigenous, LGBTIQA+ and migrant communities. Prior to their work in youth substance use prevention research and program implementation in Canada, they worked in academic and nonprofit organizations in the areas of community-based health promotion and healthcare diversity and cultural competence in Australia and New Zealand.